Exelixis is a biotechnology company that develops and commercializes small molecule therapies for cancer and other serious diseases.
The Scientist III will support multidisciplinary research teams by designing and executing preclinical in vivo studies in rodents. The successful candidate will integrate pharmacokinetics with pharmacodynamics/efficacy and/or toxicology to provide assessments around drug exposure relationship to target-engagement/efficacy and/or tox signals.
Exelixis is a biotechnology company that develops and commercializes small molecule therapies for cancer and other serious diseases.
Exelixis